These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Restoration of Patency to Central Airways Occluded by Malignant Endobronchial Tumors Using Intratumoral Injection of Cisplatin. Mehta HJ; Begnaud A; Penley AM; Wynne J; Malhotra P; Fernandez-Bussy S; Cope J; Shuster JJ; Jantz MA Ann Am Thorac Soc; 2015 Sep; 12(9):1345-50. PubMed ID: 26072968 [TBL] [Abstract][Full Text] [Related]
8. Administration of wild-type p53 adenoviral vector synergistically enhances the cytotoxicity of anti-cancer drugs in human lung cancer cells irrespective of the status of p53 gene. Inoue A; Narumi K; Matsubara N; Sugawara S; Saijo Y; Satoh K; Nukiwa T Cancer Lett; 2000 Aug; 157(1):105-12. PubMed ID: 10893449 [TBL] [Abstract][Full Text] [Related]
9. Endobronchial intratumoral chemotherapy (EITC) followed by surgery in early non-small cell lung cancer with polypoid growth causing erroneous impression of advanced disease. Celikoglu SI; Celikoglu F; Goldberg EP Lung Cancer; 2006 Dec; 54(3):339-46. PubMed ID: 17045361 [TBL] [Abstract][Full Text] [Related]
10. Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement. Roth JA; Swisher SG; Merritt JA; Lawrence DD; Kemp BL; Carrasco CH; El-Naggar AK; Fossella FV; Glisson BS; Hong WK; Khurl FR; Kurie JM; Nesbitt JC; Pisters K; Putnam JB; Schrump DS; Shin DM; Walsh GL Semin Oncol; 1998 Jun; 25(3 Suppl 8):33-7. PubMed ID: 9704675 [TBL] [Abstract][Full Text] [Related]
11. Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer. Fujiwara T; Tanaka N; Kanazawa S; Ohtani S; Saijo Y; Nukiwa T; Yoshimura K; Sato T; Eto Y; Chada S; Nakamura H; Kato H J Clin Oncol; 2006 Apr; 24(11):1689-99. PubMed ID: 16505415 [TBL] [Abstract][Full Text] [Related]
12. A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer. Wolf JK; Bodurka DC; Gano JB; Deavers M; Ramondetta L; Ramirez PT; Levenback C; Gershenson DM Gynecol Oncol; 2004 Aug; 94(2):442-8. PubMed ID: 15297186 [TBL] [Abstract][Full Text] [Related]
13. Docetaxel plus trans-tracheal injection of adenoviral-mediated p53 versus docetaxel alone in patients with previously treated non-small-cell lung cancer. Ning X; Sun Z; Wang Y; Zhou J; Chen S; Chen D; Zhang H Cancer Gene Ther; 2011 Jun; 18(6):444-9. PubMed ID: 21455255 [TBL] [Abstract][Full Text] [Related]
14. Multigene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Nakajima T; Yasufuku K; Nakagawara A; Kimura H; Yoshino I Chest; 2011 Nov; 140(5):1319-1324. PubMed ID: 21527506 [TBL] [Abstract][Full Text] [Related]
15. Effects of para-toluenesulfonamide intratumoral injection on non-small cell lung carcinoma with severe central airway obstruction: A multi-center, non-randomized, single-arm, open-label trial. Li SY; Li Q; Guan WJ; Huang J; Yang HP; Wu GM; Jin FG; Hu CP; Chen LA; Xu GL; Liu SZ; Wu CG; Han BH; Xiang Y; Zhao JP; Wang J; Zhou X; Li HP; Zhong NS Lung Cancer; 2016 Aug; 98():43-50. PubMed ID: 27393505 [TBL] [Abstract][Full Text] [Related]
16. CT-guided intratumoral gene therapy in non-small-cell lung cancer. Kauczor HU; Schuler M; Heussel CP; von Weymarn A; Bongartz G; Rochlitz C; Huber C; Thelen M Eur Radiol; 1999; 9(2):292-6. PubMed ID: 10101653 [TBL] [Abstract][Full Text] [Related]
17. Bronchoscopic intratumoral injections of cisplatin and endostar as concomitants of standard chemotherapy to treat malignant central airway obstruction. Jiang W; Yang X; Wang X; Li Y; Yang X; Wang N; Yin B Postgrad Med J; 2022 Feb; 98(1156):104-112. PubMed ID: 33070116 [TBL] [Abstract][Full Text] [Related]
18. Prospective Multicentered Safety and Feasibility Pilot for Endobronchial Intratumoral Chemotherapy. Yarmus L; Mallow C; Akulian J; Lin CT; Ettinger D; Hales R; Voong KR; Lee H; Feller-Kopman D; Semaan R; Seward K; Wahidi MM Chest; 2019 Sep; 156(3):562-570. PubMed ID: 30776363 [TBL] [Abstract][Full Text] [Related]
19. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Swisher SG; Roth JA; Komaki R; Gu J; Lee JJ; Hicks M; Ro JY; Hong WK; Merritt JA; Ahrar K; Atkinson NE; Correa AM; Dolormente M; Dreiling L; El-Naggar AK; Fossella F; Francisco R; Glisson B; Grammer S; Herbst R; Huaringa A; Kemp B; Khuri FR; Kurie JM; Liao Z; McDonnell TJ; Morice R; Morello F; Munden R; Papadimitrakopoulou V; Pisters KM; Putnam JB; Sarabia AJ; Shelton T; Stevens C; Shin DM; Smythe WR; Vaporciyan AA; Walsh GL; Yin M Clin Cancer Res; 2003 Jan; 9(1):93-101. PubMed ID: 12538456 [TBL] [Abstract][Full Text] [Related]
20. A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: safety, efficacy, and biologic activity of a novel gene-therapy approach. Cristofanilli M; Krishnamurthy S; Guerra L; Broglio K; Arun B; Booser DJ; Menander K; Van Wart Hood J; Valero V; Hortobagyi GN Cancer; 2006 Sep; 107(5):935-44. PubMed ID: 16874816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]